ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Clinical trials for ESTROGEN RECEPTOR-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Study tests quick radiation blast before breast cancer surgery
Disease control CompletedThis small, completed study tested whether a short, highly targeted course of radiation given before surgery was a practical option for older women with early-stage, hormone-sensitive breast cancer. The goal was to see if this approach could shrink the tumor and potentially allow…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 00:50 UTC
-
Major trial tests new approach to keep breast cancer at bay
Disease control CompletedThis large study tested whether temporarily shutting down the ovaries and adding different hormone-blocking drugs could better prevent breast cancer from returning compared to standard treatment alone. It involved over 3,000 premenopausal women who had surgery for hormone-sensiti…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New combo therapy tested to control advanced breast cancer
Disease control CompletedThis study tested a combination of two oral drugs, palbociclib and tamoxifen, as the first treatment for women with advanced hormone-positive breast cancer that had spread. The goal was to see how long the treatment could control the cancer's growth and how well patients tolerate…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Oana Danciu, MD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC